CN112401097A - 一种鹿参固体饮料及其制备方法 - Google Patents
一种鹿参固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN112401097A CN112401097A CN202011280187.7A CN202011280187A CN112401097A CN 112401097 A CN112401097 A CN 112401097A CN 202011280187 A CN202011280187 A CN 202011280187A CN 112401097 A CN112401097 A CN 112401097A
- Authority
- CN
- China
- Prior art keywords
- parts
- deer
- solid beverage
- ginseng
- jilin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 56
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 56
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 56
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 56
- 241000282994 Cervidae Species 0.000 title claims abstract description 53
- 235000013361 beverage Nutrition 0.000 title claims abstract description 39
- 239000007787 solid Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000008280 blood Substances 0.000 claims abstract description 55
- 210000004369 blood Anatomy 0.000 claims abstract description 55
- 241000283007 Cervus nippon Species 0.000 claims abstract description 35
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 17
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 17
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 17
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 17
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 17
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 17
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 17
- 244000197580 Poria cocos Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 241000405414 Rehmannia Species 0.000 claims abstract description 17
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 17
- 235000006533 astragalus Nutrition 0.000 claims abstract description 17
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 8
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 8
- 244000237330 gutta percha tree Species 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 15
- 235000014347 soups Nutrition 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 10
- 244000061520 Angelica archangelica Species 0.000 claims description 9
- 241001061264 Astragalus Species 0.000 claims description 9
- 241000208688 Eucommia Species 0.000 claims description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 9
- 210000004233 talus Anatomy 0.000 claims description 9
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 4
- 230000036541 health Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 206010070863 Toxicity to various agents Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229950007002 phosphocreatine Drugs 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及保健品技术领域,特别涉及一种鹿参固体饮料及其制备方法;该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血20~30份、长白山人参5~15份、山药5~10份、枸杞7~10份、黄芪8~15份、当归3~5份、熟地2~4份、茯苓6~8份和杜仲1~3份。本发明的目的在于提供一种鹿参固体饮料及其制备方法,该鹿参固体饮料具有益气补血作用,能够有效解决身体缺血导致的亚健康症状及促进身体的新陈代谢,增加免疫力,增强抵抗力。
Description
技术领域
本发明涉及保健品技术领域,特别涉及一种鹿参固体饮料及其制备方法。
背景技术
随着我国经济的高速发展,人民生活水平的提高,人们对食品提出了越来越高的要求。鹿全身都是宝,不仅鹿茸具有良好的保健作用和药用功效,其他如鹿鞭、鹿蹄筋、鹿胰脏、鹿胎膏等鹿产品都具有很好的保健和药用价值。而采用梅花鹿血与中药成药结合,制成保健品的开发和利用尚处在探索阶段。
梅花鹿血的成分主要包括鹿血含水量为80%~81%和有机物占16%~17%,其中有机物主要是蛋白质,蛋白质中富含19种氨基酸及多种酶类,另外还含多种脂类、游离脂肪酸类、固醇类、磷脂类、激素类、维生素类和多糖类等,灰分占3%~4%,并含多种常量和有益微量元素;特别是鹿血中还含有Y-球蛋白,胱氨酸、赖氨酸,与心脏机能相关的磷酸肌酸激酶、覆酶等。梅花鹿血的功效在明朝李时珍的《本草纲目》中就已经有记载:"鹿血主阳萎、补虚、止腰痛,鼻衄、跌伤、狂犬伤,和酒服治肺痿吐血,及崩中带下,诸气痛欲危者饮之立愈。大补虚损,益精血,解痘毒、药毒。养血益精、行血祛瘀、消肿疗伤。明代李时珍则对鹿血的医疗作用做了较为详细的研究,在《本草纲目》中记载为大补虚损,益精血,解痘毒、药毒等。通过动物实验和临床研究证明了鹿血确实具有养颜容、治疗贫血,调节免疫,延缓衰老,改善记忆,抗疲劳,改善性功能等多项治疗保健作用。
为此,提出一种鹿参固体饮料及其制备方法。
发明内容
本发明的目的在于提供一种鹿参固体饮料及其制备方法,该鹿参固体饮料具有益气补血作用,能够有效解决身体缺血导致的亚健康症状及促进身体的新陈代谢,增加免疫力,增强抵抗力。
为了实现上述目的,本发明的技术方案如下:
一种鹿参固体饮料,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血20~30份、长白山人参5~15份、山药5~10份、枸杞 7~10份、黄芪8~15份、当归3~5份、熟地2~4份、茯苓6~8 份和杜仲1~3份。
具体的,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血 22~25份、长白山人参9~13份、山药6~9份、枸杞7~8份、黄芪10~13份、当归4~5份、熟地3~4份、茯苓7~8份和杜仲1~ 2份。
具体的,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血 23份、长白山人参11份、山药8份、枸杞8份、黄芪12份、当归 4.5份、熟地3.5份、茯苓7份和杜仲2份。
进一步的,本发明涉及的吉林梅花鹿鹿血为新鲜的吉林梅花鹿鹿血。
一种鹿参固体饮料的制备方法,包括以下步骤:
S1:按各组份备好原料;
S2:将吉林梅花鹿鹿血与白酒按照5:1的比例混合搅拌,搅拌充分后,再将陈皮装入纱布制成的辅料包,至于吉林梅花鹿鹿血中蒸沸 30分钟,将吉林梅花鹿鹿血蒸透后起锅放置在干净的玻璃容器中,将玻璃瓶口放一层干净的纱布,在太阳下晒1小时,重复蒸晒步骤一共三次,备用;
S3:将长白山人参、黄芪、当归、熟地、茯苓和杜仲按照配方混合,得到混合物A,将混合物A与清水按照1:6的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,将汤汁倒出备用,将残渣与清水按照1:3的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,与前次汤汁收集在一起备用;
S4:将山药和枸杞按照配方混合,粉碎至300目备用;
S5:将S2步处理后的吉林梅花鹿鹿血、S3步处理后的汤汁以及 S4步处理后的粉碎物混合,真空低温浓缩,并进行真空微波干燥,干燥研磨后包装,完成鹿参固体饮料的制备。
具体的,所述S2步骤中的搅拌时间为25~30分钟,所述S2步骤中的搅拌速度为100~120转/分钟。
具体的,所述S5步骤中真空低温浓缩的真空度为8~15千帕,所述S5步骤中真空低温浓缩的温度为5~8摄氏度。
具体的,所述S5步骤中真空微波干燥的真空度为120~180帕,所述S5步骤中真空微波干燥的微波功率为700~800瓦。
具体的,所述S5步骤中研磨至100目。
本发明的有益效果为:
(1)本发明采用的吉林梅花鹿鹿血、长白山人参、山药、枸杞、黄芪、当归、熟地、茯苓和杜仲为原材料进行鹿参固体饮料的制备,其制备工艺简单,不仅能够有效降低吉林梅花鹿鹿血的含水量,还能够分解掉吉林梅花鹿鹿血中的代谢物质,制得的鹿参固体饮料纯度高,针对性强,能够有效解决身体缺血导致的亚健康症状及促进身体的新陈代谢,增加免疫力,增强抵抗力;
(2)本发明采用陈皮作为辅料包,能够较好的去掉吉林梅花鹿鹿血中的腥味,且配方中不添加任何添加剂色素以及防腐剂,口感好;
(3)本发明采用长白山人参、黄芪、当归、熟地、茯苓和杜仲相互配合,具有益气补血作用,可以有效保护女性生殖健康,暖宫暖胃,针对女性生理期流血过量,导致的贫血造成身体免疫力低下,代谢功能下降等不适症状,可以起到显著增强抵抗力的作用,再辅以山药和枸杞佐药,共同配合增强提高免疫力、增强抵抗力的效果;
(4)本发明所制得的鹿参固体饮料适用面广,不仅女性适用,同时对工作压力大的年轻人、中年人以及老年人也适用,提高免疫力,益气补血,使精神更充沛。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种鹿参固体饮料,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血23份、长白山人参11份、山药8份、枸杞8份、黄芪 12份、当归4.5份、熟地3.5份、茯苓7份和杜仲2份。
一种鹿参固体饮料的制备方法,包括以下步骤:
S1:按各组份备好原料;
S2:将吉林梅花鹿鹿血与白酒按照5:1的比例混合搅拌,搅拌充分后,再将陈皮装入纱布制成的辅料包,至于吉林梅花鹿鹿血中蒸沸 30分钟,将吉林梅花鹿鹿血蒸透后起锅放置在干净的玻璃容器中,将玻璃瓶口放一层干净的纱布,在太阳下晒1小时,重复蒸晒步骤一共三次,备用;
S3:将长白山人参、黄芪、当归、熟地、茯苓和杜仲按照配方混合,得到混合物A,将混合物A与清水按照1:6的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,将汤汁倒出备用,将残渣与清水按照1:3的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,与前次汤汁收集在一起备用;
S4:将山药和枸杞按照配方混合,粉碎至300目备用;
S5:将S2步处理后的吉林梅花鹿鹿血、S3步处理后的汤汁以及 S4步处理后的粉碎物混合,真空低温浓缩,并进行真空微波干燥,干燥研磨后包装,完成鹿参固体饮料的制备。
具体的,所述S2步骤中的搅拌时间为25~30分钟,所述S2步骤中的搅拌速度为100~120转/分钟。
具体的,所述S5步骤中真空低温浓缩的真空度为8~15千帕,所述S5步骤中真空低温浓缩的温度为5~8摄氏度。
具体的,所述S5步骤中真空微波干燥的真空度为120~180帕,所述S5步骤中真空微波干燥的微波功率为700~800瓦。
具体的,所述S5步骤中研磨至100目。
实施例2
本实施例中鹿参固体饮料的制备方法同实施例1,不同之处在于,一种鹿参固体饮料,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血20份、长白山人参5份、山药5份、枸杞7份、黄芪8份、当归3份、熟地2份、茯苓6份和杜仲1份。
实施例3
本实施例中鹿参固体饮料的制备方法同实施例1,不同之处在于,一种鹿参固体饮料,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血30份、长白山人参15份、山药10份、枸杞10份、黄芪15 份、当归5份、熟地4份、茯苓8份和杜仲3份。
实施例4
本实施例中鹿参固体饮料的制备方法同实施例1,不同之处在于,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血22份、长白山人参9份、山药6份、枸杞7份、黄芪10份、当归4份、熟地3 份、茯苓7份和杜仲1份。
实施例5
本实施例中鹿参固体饮料的制备方法同实施例1,不同之处在于,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血25份、长白山人参13份、山药9份、枸杞8份、黄芪13份、当归5份、熟地4 份、茯苓8份和杜仲2份。
对实施例1~5进行理化、微生物检测,其功效成分各项技术指标达到DB22/T172要求;其稳定性各项指标符合 GB/T5009.2.4.5.11.12.17和GB/T4879.2.3.4.5.10.11.15以及 Q/JLHDT01的要求。
对实施例1~5进行口味评鉴实验,经过100人的品尝,有96人表示喜欢本发明的益气补血、提高免疫力的功效,有2人表示不喜欢本发明的益气补血、提高免疫力的功效,剩余2人表示本发明的益气补血、提高免疫力的功效感觉一般,由此可见,大众对本发明的益气补血、提高免疫力的功效接收程度很高。
食用例1:章某某,女,38岁,***患者,表现为:面色苍白、***以及四肢冰凉,采用本发明的益气补血、提高免疫力的鹿参固体饮料后,在使用2个月以后,面色红润、精神大好、身体有力以及四肢温暖,生活也基本恢复正常。
食用例2:孙某某,男,30岁,亚健康患者,表现为:记忆力下降、失眠疲劳以及食欲不佳,且抵抗力差,容易生病,采用本发明的益气补血、提高免疫力的鹿参固体饮料后,在使用3个月以后,记忆力变好、睡眠充足、精力充沛、饮食正常以及不易生病,生活也基本恢复正常。
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。
Claims (8)
1.一种鹿参固体饮料,其特征在于,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血20~30份、长白山人参5~15份、山药5~10份、枸杞7~10份、黄芪8~15份、当归3~5份、熟地2~4份、茯苓6~8份和杜仲1~3份。
2.根据权利要求1所述的一种鹿参固体饮料,其特征在于,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血22~25份、长白山人参9~13份、山药6~9份、枸杞7~8份、黄芪10~13份、当归4~5份、熟地3~4份、茯苓7~8份和杜仲1~2份。
3.根据权利要求1所述的一种鹿参固体饮料,其特征在于,该鹿参固体饮料按以下质量份数组成:吉林梅花鹿鹿血23份、长白山人参11份、山药8份、枸杞8份、黄芪12份、当归4.5份、熟地3.5份、茯苓7份和杜仲2份。
4.一种鹿参固体饮料的制备方法,其特征在于,包括以下步骤:
S1:按各组份备好原料;
S2:将吉林梅花鹿鹿血与白酒按照5:1的比例混合搅拌,搅拌充分后,再将陈皮装入纱布制成的辅料包,至于吉林梅花鹿鹿血中蒸沸30分钟,将吉林梅花鹿鹿血蒸透后起锅放置在干净的玻璃容器中,将玻璃瓶口放一层干净的纱布,在太阳下晒1小时,重复蒸晒步骤一共三次,备用;
S3:将长白山人参、黄芪、当归、熟地、茯苓和杜仲按照配方混合,得到混合物A,将混合物A与清水按照1:6的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,将汤汁倒出备用,将残渣与清水按照1:3的比例混合熬煮,大火煮沸后,转文火熬制2小时,过滤,与前次汤汁收集在一起备用;
S4:将山药和枸杞按照配方混合,粉碎至300目备用;
S5:将S2步处理后的吉林梅花鹿鹿血、S3步处理后的汤汁以及S4步处理后的粉碎物混合,真空低温浓缩,并进行真空微波干燥,干燥研磨后包装,完成鹿参固体饮料的制备。
5.根据权利要求4所述的一种鹿参固体饮料的制备方法,其特征在于,所述S2步骤中的搅拌时间为25~30分钟,所述S2步骤中的搅拌速度为100~120转/分钟。
6.根据权利要求4所述的一种鹿参固体饮料的制备方法,其特征在于,所述S5步骤中真空低温浓缩的真空度为8~15千帕,所述S5步骤中真空低温浓缩的温度为5~8摄氏度。
7.根据权利要求4所述的一种鹿参固体饮料的制备方法,其特征在于,所述S5步骤中真空微波干燥的真空度为120~180帕,所述S5步骤中真空微波干燥的微波功率为700~800瓦。
8.根据权利要求4所述的一种鹿参固体饮料的制备方法,其特征在于,所述S5步骤中研磨至100目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280187.7A CN112401097A (zh) | 2020-11-16 | 2020-11-16 | 一种鹿参固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280187.7A CN112401097A (zh) | 2020-11-16 | 2020-11-16 | 一种鹿参固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112401097A true CN112401097A (zh) | 2021-02-26 |
Family
ID=74831328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011280187.7A Pending CN112401097A (zh) | 2020-11-16 | 2020-11-16 | 一种鹿参固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112401097A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113519748A (zh) * | 2021-07-29 | 2021-10-22 | 黄凯峰 | 一种固体保健饮料及其制备方法及应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101362998A (zh) * | 2007-08-08 | 2009-02-11 | 毛宗芳 | 一种滋补药酒的制作方法 |
CN101983700A (zh) * | 2010-11-11 | 2011-03-09 | 沈阳三山鹿业发展有限公司 | 一种中草药复配鹿血粉及其制作方法 |
CN101352510B (zh) * | 2007-07-26 | 2011-12-28 | 江苏康缘药业股份有限公司 | 一种提高机体免疫力的鹿血酒及其制备方法 |
CN105146667A (zh) * | 2015-08-13 | 2015-12-16 | 张洪义 | 鹿胎阿胶固体饮料及其生产工艺 |
CN107513486A (zh) * | 2017-10-31 | 2017-12-26 | 桐梓县贵荣梅花鹿养殖场 | 一种梅花鹿血酒的制备方法 |
CN108236656A (zh) * | 2018-02-06 | 2018-07-03 | 江西天元药业有限公司 | 一种增强免疫力、养颜美容、滋润女性肾功能的膏滋 |
CN111227239A (zh) * | 2020-03-11 | 2020-06-05 | 中科花鹿农业发展有限公司 | 一种气血双补、抗衰养巢的鹿血冻干粉软胶囊及其制备方法 |
CN111729031A (zh) * | 2020-07-14 | 2020-10-02 | 上海拜汶生物医药股份有限公司 | 中药组合物及其制备方法和应用、中药制剂 |
CN111909817A (zh) * | 2020-08-12 | 2020-11-10 | 贵州源茂农业开发有限公司 | 一种梅花鹿血酒的制作工艺 |
CN112690449A (zh) * | 2020-12-01 | 2021-04-23 | 建昌帮药业有限公司 | 一种中老年谷物调理粥 |
-
2020
- 2020-11-16 CN CN202011280187.7A patent/CN112401097A/zh active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101352510B (zh) * | 2007-07-26 | 2011-12-28 | 江苏康缘药业股份有限公司 | 一种提高机体免疫力的鹿血酒及其制备方法 |
CN101362998A (zh) * | 2007-08-08 | 2009-02-11 | 毛宗芳 | 一种滋补药酒的制作方法 |
CN101983700A (zh) * | 2010-11-11 | 2011-03-09 | 沈阳三山鹿业发展有限公司 | 一种中草药复配鹿血粉及其制作方法 |
CN105146667A (zh) * | 2015-08-13 | 2015-12-16 | 张洪义 | 鹿胎阿胶固体饮料及其生产工艺 |
CN107513486A (zh) * | 2017-10-31 | 2017-12-26 | 桐梓县贵荣梅花鹿养殖场 | 一种梅花鹿血酒的制备方法 |
CN108236656A (zh) * | 2018-02-06 | 2018-07-03 | 江西天元药业有限公司 | 一种增强免疫力、养颜美容、滋润女性肾功能的膏滋 |
CN111227239A (zh) * | 2020-03-11 | 2020-06-05 | 中科花鹿农业发展有限公司 | 一种气血双补、抗衰养巢的鹿血冻干粉软胶囊及其制备方法 |
CN111729031A (zh) * | 2020-07-14 | 2020-10-02 | 上海拜汶生物医药股份有限公司 | 中药组合物及其制备方法和应用、中药制剂 |
CN111909817A (zh) * | 2020-08-12 | 2020-11-10 | 贵州源茂农业开发有限公司 | 一种梅花鹿血酒的制作工艺 |
CN112690449A (zh) * | 2020-12-01 | 2021-04-23 | 建昌帮药业有限公司 | 一种中老年谷物调理粥 |
Non-Patent Citations (3)
Title |
---|
王达: "益血生胶囊择时给药预防化疗后白细胞减少52例", 《中国民间疗法》 * |
赵洪静,等: "中国保健(功能)饮料分析", 《中国食品学报》 * |
黎源: "归肾丸加味联合耳穴治疗月经过少临床分析", 《内蒙古中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113519748A (zh) * | 2021-07-29 | 2021-10-22 | 黄凯峰 | 一种固体保健饮料及其制备方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103740566B (zh) | 一种刺梨药酒及其制作方法 | |
CN102965235B (zh) | 一种板栗养生酒 | |
CN103627610A (zh) | 一种复方红景天酒及其制备方法 | |
US10987396B2 (en) | Composition for improving internal circulation and delaying aging and application thereof | |
CN103416768B (zh) | 一种滋阴补肾的鳄鱼肉组合物及其制备方法 | |
CN103393739A (zh) | 一种壮阳补肾的鳄鱼鞭组合物及其制备方法 | |
CN108671002B (zh) | 一种含雪莲培养物提取物的组合物及其应用 | |
CN108236656A (zh) | 一种增强免疫力、养颜美容、滋润女性肾功能的膏滋 | |
CN104946488B (zh) | 养生龟酒及其制备方法 | |
CN102578666A (zh) | 一种石斛饮料 | |
CN106728386A (zh) | 一种调理气血,调经养颜膏滋及其制备方法 | |
CN107334097B (zh) | 一种海参浸提膏的制备方法和应用 | |
CN112401097A (zh) | 一种鹿参固体饮料及其制备方法 | |
CN103082240B (zh) | 一种胡萝卜参的加工方法 | |
CN101480471B (zh) | 一种治疗帕金森氏病的药物及其制备方法 | |
CN110464775B (zh) | 一种金银花口服减肥药及其制备方法 | |
CN106666733A (zh) | 一种造血补肾乌发强壮功能的滋补膏 | |
CN111588029A (zh) | 一种黄精膏组合物 | |
CN106350411A (zh) | 一种保健养生酒的制备方法 | |
CN106942659B (zh) | 一种山苦瓜保健含片的制作方法 | |
CN112587612A (zh) | 一种牡蛎鹿鞭膏及其制备方法 | |
CN105733880A (zh) | 一种以榛子粕为原料酿制的复合榛子酒 | |
CN109077954A (zh) | 虫草面膜 | |
CN107348479A (zh) | 一种低能量复合益生菌草本酵素膏滋补品的制备方法 | |
KR20100129040A (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210226 |